Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|February 18, 2021
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemiaDaniele Caracciolo, Caterina Riillo, Andrea Ballerini, et al.
American Journal of Hematology|July 29, 2020
Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: Data from 151 patientsJulien Rohmer, Amélie Couteau-Chardon, Julie Trichereau, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 1, 2019
Standardization of Flow Cytometric Immunophenotyping for Hematological Malignancies: The FranceFlow Group ExperienceFrançoise Solly, Fanny Angelot-Delettre, Michel Ticchioni, et al.
American Journal of Hematology|April 6, 2024
Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot studyJosquin Moraly, Julien Rossignol, Claire Rouzaud, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 25, 2022
Effective Anti-SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJulien Rossignol, Amani Ouedrani, Cristina Bulai Livideanu, et al.
The Journal of Allergy and Clinical Immunology|August 26, 2023
Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypesLaura Polivka, Marine Madrange, Cristina Bulai-Livideanu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 30, 2024
Histological characterization of liver involvement in systemic mastocytosisJulien Rossignol, Danielle Canioni, Achille Aouba, et al.
Leukemia|January 23, 2021
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trialFrancois Guilhot, Françoise Rigal-Huguet, Joëlle Guilhot, et al.
Blood|November 5, 2020
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome-negative adult lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Juana Ciudad, et al.
The Journal of Allergy and Clinical Immunology|January 13, 2023
Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patientsQuentin Riller, Jacques Fourgeaud, Julie Bruneau, et al.
Pageof 8